==HOOKIPA Pharma (HOOK) announces $21.25 million equity investment from Gilead Sciences (GILD)

 

HOOKIPA Pharma (HOOK) announces $21.25 million equity investment from GILD 

• HOOK announced that GILD has purchased 15 million shares of HOOKIPA's common stock for approximately $21.25 million, at a price of $1.4167 per share.
• In addition, HOOKIPA has the right, subject to certain terms and conditions, to sell an additional approximately $8.75 million of common stock to Gilead as pro-rata participation in potential future equity raises. The agreement with Gilead replaces the stock purchase agreement that Hookipa entered into with Gilead in 2022.
• The transaction closed on December 20, 2023. Following the completion of the stock purchase, Gilead's ownership in HOOKIPA increased to 18,759,465 shares, or approximately 19.4% of HOOKIPA's outstanding shares of Common Stock.